Literature DB >> 17233386

[Etiology and outcome of community-acquired pneumonia in relation to age and severity in hospitalized adult patients].

Noboru Takayanagi1, Kenichiro Hara, Daidou Tokunaga, Youtaro Takaku, Shunsuke Minagawa, Yutaka Tsuchiya, Naoya Hijikata, Tomohisa Yamaji, Hiroo Saito, Mikio Ubukata, Kazuyoshi Kurashima, Tsutomu Yanagisawa, Yutaka Sugita.   

Abstract

The aim of this study was to determine the etiology and outcome of community-acquired pneumonia (CAP) in relation to age and severity in hospitalized patients. Overall, 652 consecutive patients with CAP were studied retrospectively during a 4-year period from 2002. Severity of pneumonia was classified according to the guidelines of the Japanese Respiratory Society (JRS 2005) and American Thoracic Society (ATS 2001). The etiology was identified in 401 of 652 (61.5%) cases. The four most frequent pathogens were Streptococcus pneumoniae (26.2%), influenza virus (12.4%), Mycoplasma pneumoniae (10.9%), and Haemophilus influenzae (5.9%). The most common pathogen in the younger (15-44 years) group and very severe patients (JRS) was Mycoplasma pneumoniae (38.4%) and influenza virus (28.6%), respectively. The three most frequent pathogens in severe CAP patients (ATS) were Streptococcus pneumoniae (29.0%), influenza virus (17.4%), and Legionella species (13.0%). The overall mortality was 6.4%. The mortality of CAP patients among aged 1544, 45-64, 65-74, and 75 years or older was 1.4%, 3.3%, 6.9% and 9.3%, respectively. The mortality of mild, moderate, severe, and very severe patients (RS) was 0%, 4.1%, 15.5%, and 53.6%, respectively. The mortality of non-severe and severe patients (ATS) was 1.8% and 23.9%, respectively. Age and severity had influence on the prevalence of the main microbial pathogens. Streptococcus pneumoniae remained the most important pathogen that needs consideration in initial antibiotic therapy in patients with CAP of all ages and severities. Pathogens identified in patients with severe CAP in Japan were similar to those of Western countries, except for the high incidence of the influenza virus.

Entities:  

Mesh:

Year:  2006        PMID: 17233386

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  4 in total

Review 1.  Chest physiotherapy for pneumonia in adults.

Authors:  Xiaomei Chen; Jiaojiao Jiang; Renjie Wang; Hongbo Fu; Jing Lu; Ming Yang
Journal:  Cochrane Database Syst Rev       Date:  2022-09-06

2.  Discrimination between Legionnaires' Disease and Pneumococcal Pneumonia Based on the Clinical and Laboratory Features: A Quantitative Approach Using the Modified Winthrop-University Hospital Weighted Point System.

Authors:  Hiroki Yamakuchi; Yohei Hamada; Tosiharu Urakami; Yosuke Aoki
Journal:  Intern Med       Date:  2017-03-01       Impact factor: 1.271

Review 3.  Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.

Authors:  Bin Cao; Yi Huang; Dan-Yang She; Qi-Jian Cheng; Hong Fan; Xin-Lun Tian; Jin-Fu Xu; Jing Zhang; Yu Chen; Ning Shen; Hui Wang; Mei Jiang; Xiang-Yan Zhang; Yi Shi; Bei He; Li-Xian He; You-Ning Liu; Jie-Ming Qu
Journal:  Clin Respir J       Date:  2017-09-26       Impact factor: 2.570

4.  Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia.

Authors:  Xiudi Han; Fei Zhou; Hui Li; Xiqian Xing; Liang Chen; Yimin Wang; Chunxiao Zhang; Xuedong Liu; Lijun Suo; Jinxiang Wang; Guohua Yu; Guangqiang Wang; Xuexin Yao; Hongxia Yu; Lei Wang; Meng Liu; Chunxue Xue; Bo Liu; Xiaoli Zhu; Yanli Li; Ying Xiao; Xiaojing Cui; Lijuan Li; Jay E Purdy; Bin Cao
Journal:  BMC Infect Dis       Date:  2018-04-24       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.